News

Published on 2 Dec 2022 on Insider Monkey via Yahoo Finance

10 Pump and Dump Stocks Hedge Funds Like


Article preview image

In this article, we discuss the 10 pump and dump stocks hedge funds like. If you want to read about some more pump and dump stocks, go directly to 5 Pump and Dump Stocks Hedge Funds Like.

The influx of retail investors on the stock market in recent months and the rise of social media speculation around meme stocks has given strong momentum to pump and dump schemes. This is a phenomenon not limited to just the United States but spread across the world. On August 11, the Singapore police warned traders of “a resurgence in pump and dump schemes” after seven people lost more than $1 million through investments in a publicly-traded equity. In the US, legendary investors like Mario Gabelli have raised similar warnings. 

To understand pump and dump schemes, a small introduction to penny stocks is also important. Penny stocks are more popular than ever, enticing investors with low entry costs and the possibility of large financial gains. Stories of shares increasing in value by more than 4,000% in a matter of months add to their allure, and new trading technology makes it easier than ever to enter the market. However, while penny stocks can be profitable, they also carry a high level of risk, which must be balanced with value investments. 

NASDAQ.WKHS price evolution
NASDAQ.BXRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Here's Why Baudax Bio, Inc. (BXRX) Is a Great 'Buy the Bottom' Stock Now

The price trend for Baudax Bio, Inc. (BXRX) has been bearish lately and the stock has lost 9.1% o...

Zacks via Yahoo Finance 18 Sep 2023

Baudax Bio (BXRX) Up 125% on Acquiring TeraImmune

Baudax Bio BXRX acquired TeraImmune, a privately held company that’s focused on the discovery and...

Zacks via Yahoo Finance 3 Jul 2023

Baudax (BXRX) Up on New Neuromuscular Blocking Agent Study Data

Baudax Bio, Inc. BXRX announced additional positive data from its phase II study of BX1000, which...

Zacks via Yahoo Finance 8 Jun 2023

Baudax Bio Touts Additional Positive Data From Nerve Blocker In Surgery Patients

Baudax Bio Inc (NASDAQ: BXRX) announced additional results from its Phase 2 trial of BX1000 for n...

Benzinga via Yahoo Finance 7 Jun 2023

Lab Notes: Jefferson Institute for Bioprocessing undergoing multimillion-dollar expansion

This week's life sciences industry news includes items on a bioprocessing institute's expansion...

The Business Journals 28 Apr 2023

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.57% By Investing.com

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.57%

Investing.com 27 Apr 2023

Baudax Bio Prices 3.48M Share Offerings at $1.15/sh By Investing.com

Baudax Bio, Inc. (BXRX), a pharmaceutical company focused on innovative products for hospital and...

Investing.com 27 Apr 2023

Baudax Bio Prices 3.48M Share Offerings at $1.15/sh By Investing.com

Baudax Bio, Inc. (BXRX), a pharmaceutical company focused on innovative products for hospital and...

Investing.com 26 Apr 2023

Baudax Bio's Nerve Blockade Aces Mid-Stage Study In Surgery Patients

Baudax Bio Inc (NASDAQ: BXRX) announced top-line results from its Phase 2 clinical trial of BX100...

Benzinga via Yahoo Finance 25 Apr 2023

Why Baudax Bio Shares Are Trading Higher Today

Baudax Bio Inc (NASDAQ: BXRX) announced results from the second preplanned interim analysis of it...

Benzinga via Yahoo Finance 27 Mar 2023